5. 非洲应对 COVID-19 大流行的工作在国家、区域和非洲大陆各级继续加强。2021 年 4 月，非洲联盟及下设的非洲疾病预防控制中心启动了非洲疫苗制造伙伴关系。这些伙伴关系旨在利用泛非和全球伙伴关系扩大非洲的疫苗生产规模，以便更有效地应对当前和未来的大流行病。2021 年 6 月，世界卫生组织(世卫组织)及其 COVID-19 疫苗全球获取(COVAX)机制合作伙伴与南非一个联合会(由Biovac 公司、Afrigen 生物制品与疫苗公司、一个大学网络以及非洲疾病预防控制中心组成)一道合作，建立了世卫组织首个 COVID-19 信使核糖核酸疫苗技术转让中心。2020 年 10 月，非洲疾病预防控制中心在整个非洲大陆推出了另外 6项疫情应对举措，主要针对监测和检测、医疗用品供应、公共卫生和社会措施、安全旅行、生计和经济、病原体基因组学以及疫苗开发与供应。
5. The response of Africa to the COVID-19 pandemic continued to intensify at the national, regional and continental levels. In April 2021, the African Union and its Africa Centres for Disease Control and Prevention launched the Partnerships for African Vaccine Manufacturing. The Partnerships aim to leverage pan-African and global partnerships to scale up vaccine manufacturing in Africa in order to respond more effectively to current and future pandemics. In June 2021, the World Health Organization (WHO) and its COVID-19 Vaccine Global Access (COVAX) partners joined forces with a South African consortium comprising Biovac, Afrigen Biologics and Vaccines, a network of universities and the Africa Centres for Disease Control and Prevention to establish its first COVID-19 messenger RNA vaccine technology transfer hub. In October 2020, the Africa Centres rolled out six additional pandemic response initiatives across the continent, targeting surveillance and testing, medical supply availability, public health and social measures, safe travel, livelihoods and economies, pathogen genomics and the development and supply of vaccines.